The RESOLUTE International study evaluated the Resolute stent in a large "real-world" patient population across multiple centers internationally. It found that use of the Resolute stent was associated with a low rate of major cardiac events such as death, heart attack and stent thrombosis, consistent with results from the RESOLUTE All Comers trial. The study enrolled over 2,300 patients across various countries and baseline characteristics and outcomes were similar between monitored and unmonitored patients, supporting the generalizability of prior RESOLUTE trial results.